Cutaneous manifestations of dabrafenib (GSK2118436): a...

Cutaneous manifestations of dabrafenib (GSK2118436): a selective inhibitor of mutant BRAF in patients with metastatic melanoma

Anforth, R.M., Blumetti, T.C.M.P., Kefford, R.F., Sharma, R., Scolyer, R.A., Kossard, S., Long, G.V., Fernandez-Peñas, P.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
167
Language:
english
Journal:
British Journal of Dermatology
DOI:
10.1111/j.1365-2133.2012.11155.x
Date:
November, 2012
File:
PDF, 564 KB
english, 2012
Conversion to is in progress
Conversion to is failed